Altamira Therapeutics Ltd. Adjustments For Unrealised Foreign Exchange Losses Gains
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -$1.65 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2025-08-29
CHF
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 6 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|
| 2023-12-31 | 180.35K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 66.68K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -46.09K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -33.13K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | -279.33K CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -318.32K CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 10.82K CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | 15.47K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | 21.29K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | -16.56K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 211.21K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | 151.78K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | 776.16K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 99.09K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | -1.17M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 6 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|
| 2025-06-30 | -$1.65M 6-K · filed 2025-08-29 | |
| 2024-12-31 | $573.39K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $117.92K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $200.72K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $102.93K 6-K · filed 2024-09-24 | |
| 2022-12-31 | -$48.26K 20-F · filed 2025-04-30 |